Shingles – Reoccurrence

Transcript

Since the risk of developing severe complications from zoster is more common in the elderly, individuals older than 60 should obtain the zoster vaccine, which can greatly reduce their incidence of developing herpes zoster by at least half. In those who suffer from herpes zoster after vaccination, the symptoms are less severe and post-herpetic neuralgia is also less commonly developed. The zoster vaccine is contraindicated in patients who are immunocompromised or immunosuppressed because it may cause a disseminated type of herpes zoster infection.